RFK Jr. continues serving as HHS Secretary with sustained alignment to White House priorities on MAHA initiatives, vaccine policy adjustments, and departmental reorganization. Recent leadership changes at HHS, including senior advisor elevations and operational streamlining ahead of the midterms, underscore ongoing institutional support rather than transition signals. Democratic congressional inquiries, legal challenges over advisory committee appointments, and calls for resignation from some health groups have not produced verified statements, procedural steps, or White House pressure indicating an exit before October 31. Trader pricing at 94.5% for "No" reflects the absence of acute political or institutional catalysts that historically precede cabinet departures, with Kennedy publicly focused on departmental work.